Listed by the USPTO as ALAM, DANYAL HASSAN
Tech Center 1600 • Art Units: 1600 1633 1638 1671 1672 1674 1675
This examiner grants 67% of resolved cases
Danyal Hassan Alam examines cases in Art Unit 1600 within Tech Center 1600. The examiner has 6 resolved cases and an allowance rate of 66.7 percent. The median days to allowance is 1174. The interview lift is 0.0 percent, suggesting that interviews have not historically changed the probability of allowance for this examiner based on the current data.
Lonza Houston Inc., ModernaTX Inc., and The Johns Hopkins University are the top companies. They are represented by Foley & Lardner LLP, Fox Rothschild LLP, and MARSHALL, GERSTEIN & BORUN LLP. The 66.7 percent allowance rate and 1174-day median pendency provide a baseline for expectations in this art unit. Practitioners should focus on written advocacy given the 0.0 percent interview lift.
With 6 resolved cases, the examiner's data is based on a small sample size. The 66.7 percent allowance rate is the primary success metric. Practitioners representing Lonza Houston Inc. or ModernaTX Inc. should use the 1174-day median to allowance for their planning. The 0.0 percent interview lift indicates that oral arguments have not yet shown a statistical impact on outcomes in Art Unit 1600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18555087 | RESPIRATORY VIRUS COMBINATION VACCINES | Final Rejection | ModernaTX, Inc. |
| 18555130 | INFLUENZA-CORONAVIRUS COMBINATION VACCINES | Final Rejection | ModernaTX, Inc. |
| 17767389 | HIGHLY MULTIPLEXED DETECTION OF NUCLEIC ACIDS | Final Rejection | The Johns Hopkins University |
| 17638451 | ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES | Non-Final OA | The Regents of the University of California |
| 18444305 | COMPOSITIONS AND METHODS OF USE FOR HUMAN RHINOVIRUSES | Non-Final OA | University of Utah Research Foundation |
| 18700605 | BACTERIOPHAGE PREPARATIONS AND METHODS OF USE | Non-Final OA | The United States Government As Represented By The Department of Veterans Affairs |
| 18883134 | NUCLEIC ACID VACCINES ENCAPSULATED WITH NANOALUMINOSILICATE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) | Non-Final OA | Imam Abdulrahman Bin Faisal University |
| 18833645 | BROADLY NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES TARGETING THE N-TERMINAL DOMAIN OF THE SPIKE PROTEIN AND METHODS OF USE THEREOF | Non-Final OA | The Rockefeller University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.7% of resolved applications examined by Danyal Hassan Alam were allowed (6 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Danyal Hassan Alam took 1,174 days on average from filing to allowance.
Danyal Hassan Alam examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
